UNITED STATES OF AMERICA —Cencora has entered into a definitive agreement to acquire the outstanding equity of American Oncology Network, valuing the physician-led oncology provider group at an enterprise value of $2.4 billion. The transaction structure includes $2.3 billion in cash at closing, alongside up to $100 million in contingent value rights subject to specific performance conditions. Cencora, which currently holds a minority stake, expects to increase its ownership to 75 percent, assuming certain existing stockholders participate in a 25 percent equity rollover. The acquisition is projected to become accretive to adjusted diluted earnings per share in the second year following closure, pending standard regulatory and shareholder approvals.
This development matters because it accelerates the consolidation of community-based cancer care under well-capitalized management services organizations. Independent oncology practices increasingly face financial and operational pressures from rising drug costs, complex reimbursement models, and the need for advanced technological infrastructure. By integrating this network, the acquirer can provide scalable practice management, revenue cycle support, and ancillary services, allowing physicians to maintain clinical autonomy while benefiting from institutional resources.
The broader healthcare delivery sector is experiencing a structural shift toward value-based care models, particularly in specialized fields like oncology. Regulatory frameworks and payer policies are increasingly rewarding coordinated, cost-effective care delivery outside of traditional hospital settings. This transaction directly impacts community oncology providers, pharmaceutical manufacturers, and regional healthcare systems by establishing a more unified distribution and support channel for specialized therapies and practice management solutions.
For Cencora, a global pharmaceutical solutions and distribution organization ranked among the largest corporations by revenue, this acquisition significantly broadens its management services organization capabilities. American Oncology Network, founded in 2018, operates a physician-led alliance of over 350 providers across 21 states, focusing on value-based cancer care. The integration will expand the acquirer’s geographic footprint into twelve additional states, diversifying its revenue streams beyond traditional pharmaceutical wholesale distribution and solidifying its position as a comprehensive partner for independent medical practices navigating an evolving healthcare landscape.
